AAAdil Ayub

Adil Ayub

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adil Ayub has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Adnan M. Al-Ayoubi

    Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.

    1 shared publication
  • Erik Lewis

    Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.

    1 shared publication
  • Faiz Bhora

    Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.

    1 shared publication
  • Grace Kim

    Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.

    1 shared publication
  • Norberto Santana-Rodríguez

    Universitary Institute for Research in Biomedicine and Health (IUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain

    1 shared publication
  • Sadiq Rehmani

    Department of Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, NY, U.S.A.

    1 shared publication

Latest Publications

  • Primary Non-Hodgkin’s Lymphoma of the Gallbladder: Α Population-based Analysis

    by Adil Ayub, Sadiq Rehmani, Adnan M. Al-Ayoubi, Erik Lewis, Norberto Santana-Rodríguez, Wissam Raad, Faiz Bhora, Grace Kim

    Background/Aim: Primary Non-Hodgkin's lymphoma of the gallbladder (PNHL-GB) is extremely rare and data on clinical characteristics, optimal management and outcomes of these patients are limited to anecdotal reporting. We, therefore, sought to examine these patients using a population-based database. Materials and Methods: Surveillance, epidemiology, and end results (SEER) database was queried between 1973 and 2013. Results: One hundred and six cases with PNHL-GB were identified (mean age=70.5 ±15 years, whites 92%, male: female 1.03:1). The majority of patients had loco-regional disease (61%) and DLBCL histology (33%). Ninenty cases (85%) had undergone surgical resection, 6 (5.6%) received radiotherapy. Median overall survival (OS) of the entire cohort was 41 months with a 5-year survival rate of 40%. Patients receiving adjuvant RT had superior OS compared to surgery alone (140 ±27 vs. 86 ±16 months, respectively) and patients with DLBCL demonstrated lower survival compared to other histologies (13 vs. 53 months, respectively, p=0.034). Conclusion: Our study presents the largest dataset of PNHL-GB describing clinical features and outcomes of these patients in addition to summarizing the literature.